Stock Report

All about this stock under one free report Last Updated: 23-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Aurobindo Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: AUROPHARMA | BSE: 524804

₹1,610.90

up-down-arrow ₹32.10 (2.03%)

As on 22-Oct-2026IST

Market cap

info icon

₹93,556 Cr

Revenue (TTM)

info icon

₹34,935 Cr

P/E Ratio

info icon

25.2

P/B Ratio

info icon

2.4

Div. Yield

info icon

0.2 %

Edit peer-selector-edit
Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Market cap (₹ Cr)
 93,556 1,13,217 1,03,417 94,042 88,166
Revenue (₹ Cr)
 34,935 28,592 33,228 14,738 29,967
Net Profit (₹ Cr)
 3,712.74 4,492.20 3,169.30 2,055.11 5,551.01
Net Margin (%)
 10.42 14.92 9.15 13.64 18.23
RoE (%)
 10.38 18.78 8.72 13.60 28.32
Price to Earnings
 25.20 25.09 32.10 46.04 15.95
Price-To-Book
 2.40 4.20 2.71 5.59 3.70

Income Statement (₹ Cr)

Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Operating Revenue arrow
34,935.29 28,591.70 33,227.90 14,737.88 29,966.58
Total Income arrow
35,624.79 30,111.40 34,650.70 15,061.79 30,442.31
Total Expenditure arrow
27,850.01 21,334.70 28,088.10 10,911.05 20,428.27
EBITDA arrow
7,085.28 7,257.00 5,139.80 3,826.83 9,538.31
Depreciation arrow
1,859.31 1,724.60 2,119.30 893.20 1,529.37
EBIT arrow
5,225.97 5,532.40 3,020.50 2,933.63 8,008.94
Interest arrow
387.88 510.20 416.30 578.61 452.37
Other Income arrow
689.50 1,519.70 1,422.80 323.91 475.73
Exceptional Items arrow
-105.51 -534.80 0.00 -129.75 -557.91
Profit before Tax arrow
5,422.08 6,007.10 4,027.00 2,549.18 7,474.39
Provision for Tax arrow
1,709.34 1,514.90 857.70 494.07 1,923.38
Profit after Tax arrow
3,712.74 4,492.20 3,169.30 2,055.11 5,551.01

Liabilities (₹ Cr)

Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Shareholder's Funds arrow
37,890.97 27,111.40 37,891.50 16,300.34 22,448.27
Minority Interest arrow
1.76 -79.70 38.90 -24.90 -22.18
Non-Current Liabilities arrow
2,580.33 7,112.50 3,145.10 5,011.23 3,200.22
Current Liabilities arrow
18,039.01 15,711.90 16,747.40 6,507.25 12,651.24
Total Liabilities arrow
58,196.15 50,672.60 56,576.70 27,754.83 38,146.06

Assets (₹ Cr)

Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Non-Current Assets arrow
24,040.45 31,677.20 27,204.00 20,274.65 11,888.82
Current Assets arrow
32,708.75 19,906.10 30,179.30 6,954.20 24,027.38
Total Assets arrow
58,196.15 50,672.60 56,576.70 27,754.83 38,146.06
Total Debt* arrow
7,676.20 11,769.50 7,734.10 6,021.78 5,910.20
Net Current Assets arrow
14,669.74 4,194.20 13,431.90 446.95 11,376.14
Contingent Liabilities arrow
1,358.37 989.90 336.14 924.77 1,094.02

Cashflow (₹ Cr)

Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Cash From Operating Activities arrow
5,526.37 2,116.60 5,673.70 3,121.29 7,334.50
Cash Flow from Investing Activities arrow
-3,458.61 -8,296.10 -6,549.30 -196.42 -3,864.59
Cash from Financing Activities arrow
-1,269.15 5,806.90 829.00 -2,952.69 -845.87
Net Cash Inflow / Outflow arrow
798.61 -372.60 -46.60 -27.82 2,624.04

Ratios

Profitability Ratios

 Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
ROCE (%) arrow
12.76 21.39 13.75 13.24 28.86
ROE (%) arrow
10.38 18.78 8.72 13.60 28.32
ROA (%) arrow
6.86 10.03 5.89 7.36 16.43
EBIT Margin (%) arrow
14.96 19.35 9.09 19.91 26.73
Net Margin (%) arrow
10.42 14.92 9.15 13.64 18.23
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Revenue Growth (%) arrow
9.09 21.11 -0.87 14.16 28.19
EBIT Growth (%) arrow
6.91 -8.99 -55.06 19.45 77.03
Net Profit Growth (%) arrow
8.63 -3.14 -44.66 8.09 49.13
EPS Growth (%) arrow
11.88 4.31 -43.29 12.27 60.86
Book Value Growth (%) arrow
16.04 13.19 12.99 13.74 30.75

Valuation Ratios

 Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Price / Earnings arrow
24.89 23.17 32.09 43.75 14.79
Price / Book Value arrow
2.40 4.20 2.71 5.59 3.70
Dividend Yield (%) arrow
0.25 0.09 0.65 0.04 0.93
EV/EBITDA arrow
12.79 16.23 20.26 25.62 8.90
Market Cap (₹ Cr) arrow
75,689.14 87,643.18 1,04,763.81 82,801.75 1,05,737.27

Solvency Ratios

 Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Debt to Equity arrow
0.02 0.12 0.00 0.17 0.07
Short term debt to equity ratio arrow
0.16 0.16 0.16 0.04 0.18
Current Ratio arrow
1.81 1.27 1.80 1.07 1.90
Quick Ratio arrow
1.15 0.91 1.35 0.74 1.42
Interest Coverage arrow
14.98 12.77 10.67 5.41 17.52

Operating Efficiency Ratios

 Aurobindo Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Lupin
Debtors to sales (%) arrow
20.31 18.94 30.47 11.74 22.04
Asset Turnover arrow
0.65 0.64 0.62 0.53 0.89
Receivable days arrow
33.71 33.55 103.79 39.93 51.23
Inventory Days arrow
59.32 33.80 79.94 51.78 48.93
Payable days arrow
148.20 149.82 84.78 111.46 205.75
Cash Conversion Cycle arrow
-55.17 -82.46 98.95 -19.75 -105.59
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...